CHANCELLOR MICHAEL B has a total of 26 patent applications. Its first patent ever was published in 2000. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are CELLECT BIOTHERAPEUTICS LTD, BIOVEX LTD and CHANGCHUN HUAPU BIOTECHNOLOGY CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 20 | |
#2 | WIPO (World Intellectual Property Organization) | 6 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Foods and drinks | |
#5 | Environmental technology | |
#6 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Climate change adaptation technologies | |
#5 | Enzymes | |
#6 | Analysing materials | |
#7 | Foods | |
#8 | Object sterilising | |
#9 | Electrotherapy |
# | Name | Total Patents |
---|---|---|
#1 | Chancellor Michael B | 26 |
#2 | Huard Johnny | 11 |
#3 | Jankowski Ronald | 5 |
#4 | Pruchnic Ryan | 5 |
#5 | Kaufman Jonathan H | 5 |
#6 | Qu Zhuqing | 5 |
#7 | Capelli Christopher C | 5 |
#8 | Yoshimura Naoki | 3 |
#9 | Chuang Yao-Chi | 3 |
#10 | Huang Leaf | 3 |
Publication | Filing date | Title |
---|---|---|
US2012263781A1 | Methods and compositions for treating rhinitis | |
US2013071466A1 | Methods and compositions for treating gastric disorders | |
WO2010078403A2 | Methods and compositions for diagnosing urological disorders | |
US2009004153A1 | Muscle derived cells for the treatment of urinary tract pathologies and methods of making and using same | |
US2009010897A1 | Muscle derived cells for the treatment of cardiac pathologies and methods of making and using the same | |
US2007122466A1 | Sphingomyelin liposomes for the treatment of hyperactive bladder disorders | |
US2006121006A1 | Production of nutritional and therapeutic products from cultured animal cells | |
WO03015698A2 | Application of lipid vehicles and use for drug delivery | |
US7115417B1 | Soft tissue and bone augmentation and bulking utilizing muscle-derived progenito compositions, and treatments thereof |